Buyer Name: NHS England - North West
Buyer Address: Regatta Place, Brunswick Business Park, Summers Road, Liverpool, UKD, L3 4BL, United Kingdom
Contact Email: necsu.psrprocurement@nhs.net
NHSE1063-64 Mpox Vaccination and Gonorrhoea Vaccination
Buyer Contact Info
Buyer Name: NHS England - North West Greater Manchester
Buyer Address: 4th floor Piccadilly place, London Road, MANCHESTER, UKD, M1 3BN, United Kingdom
Status
complete
complete
Procedure
limited
limited
Value
18.06 GBP
18.06 GBP
Published
05 Aug 2025, 13:33
05 Aug 2025, 13:33
Deadline
n/a
n/a
Contract Start
n/a
n/a
Contract End
n/a
n/a
Category
services
services
CPV
85140000 - Miscellaneous health services
85140000 - Miscellaneous health services
Region
n/a
n/a
Awarded To
HCRG Care Services Limited, Brook Young People, Wirral Community Health and Care NHS Foundation Trust, Locala Community Partnerships CIC, Manchester University NHS Foundation Trust, Bolton NHS Foundation Trust
HCRG Care Services Limited, Brook Young People, Wirral Community Health and Care NHS Foundation Trust, Locala Community Partnerships CIC, Manchester University NHS Foundation Trust, Bolton NHS Foundation Trust
Official Source
Open Find a Tender
Open Find a Tender
Description
NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: NHSE NW • Lot 1 - Cheshire West & Chester • Lot 2 - Blackburn with Darwen • Lot 3 - Wirral NHSE GM • Lot 4 - Rochdale, Oldham, Bury • Lot 5 - Tameside, Stockport, Wigan • Lot 6 - Manchester, Trafford and Salford • Lot 7 - Bolton- MPOX
Linked Documents
No linked documents found for this notice.
Opportunity Context
Lots
Lot Title: Lot 1 - Cheshire West and Chester
Lot Description: NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards. Following the government's acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: • a routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK • a routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK The Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. Eligibility The JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. Individuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. Activity/funding Funding of £10.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional £8.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. As these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. Delivery date Providers should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. Provider Eligibility Criteria: Eligible providers must: • Hold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. • Pass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. Contract Term: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority: Locations/Lots: NHSE NW • Lot 1 - Cheshire West & Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026. • Lot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. NHSE GM • Lot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031. • Lot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032. • Lot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority
Lot 1 Status: cancelled
Lot 1 Has Options: No
Lot 1 Award Criterion (quality): Patient Choice
Lot 1 Award Criterion (cost): Patient Choice
Lot Title: Lot 2 - Blackburn with Darwen
Lot 2 Status: cancelled
Lot 2 Has Options: No
Lot 2 Award Criterion (quality): Patient Choice
Lot 2 Award Criterion (cost): Patient Choice
Lot Title: Lot 3 - Wirral
Lot 3 Status: cancelled
Lot 3 Has Options: No
Lot 3 Award Criterion (quality): Patient Choice
Lot 3 Award Criterion (cost): Patient Choice
Lot Title: Lot 4 - Rochdale, Oldham, Bury
Lot 4 Status: cancelled
Lot 4 Has Options: No
Lot 4 Award Criterion (quality): Patient Choice
Lot 4 Award Criterion (cost): Patient Choice
Lot Title: Lot 5 - Tameside, Stockport, Wigan
Lot 5 Status: cancelled
Lot 5 Has Options: No
Lot 5 Award Criterion (quality): Patient Choice
Lot 5 Award Criterion (cost): Patient Choice
Lot Title: Lot 6 - Manchester, Trafford and Salford
Lot 6 Status: cancelled
Lot 6 Has Options: No
Lot 6 Award Criterion (quality): Patient Choice
Lot 6 Award Criterion (cost): Patient Choice
Lot Title: Lot 7 - Bolton
Lot 7 Status: cancelled
Lot 7 Has Options: No
Lot 7 Award Criterion (quality): Patient Choice
Lot 7 Award Criterion (cost): Patient Choice
Contracts
Contract Title: NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Awards
Award Title: NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination
Raw Notice JSON
Expand raw payload
{
"awards": [
{
"id": "046179-2025-Lot 1 - Cheshire West and Chester-1",
"status": "active",
"suppliers": [
{
"id": "GB-COH-07557877",
"name": "HCRG Care Services Limited"
}
],
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination"
},
{
"id": "046179-2025-Lot 2 - Blackburn with Darwen-2",
"status": "active",
"suppliers": [
{
"id": "GB-COH-02466940",
"name": "Brook Young People"
}
],
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination"
},
{
"id": "046179-2025-Lot 3 - Wirral-3",
"status": "active",
"suppliers": [
{
"id": "GB-NHS-(RY7)",
"name": "Wirral Community Health and Care NHS Foundation Trust"
}
],
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination"
},
{
"id": "046179-2025-Lot 4 - Rochdale, Oldham, and Bury-4",
"status": "active",
"suppliers": [
{
"id": "GB-COH-07557877",
"name": "HCRG Care Services Limited"
}
],
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination"
},
{
"id": "046179-2025-Lot 5 - Tameside, Stockport, and Wigan-5",
"status": "active",
"suppliers": [
{
"id": "GB-COH-07584906",
"name": "Locala Community Partnerships CIC"
}
],
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination"
},
{
"id": "046179-2025-Lot 6 - Manchester, Trafford and Salford-6",
"status": "active",
"suppliers": [
{
"id": "GB-NHS-(R0A)",
"name": "Manchester University NHS Foundation Trust"
}
],
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination"
},
{
"id": "046179-2025-Lot 7 - Bolton-7",
"status": "active",
"suppliers": [
{
"id": "GB-NHS-(RMC)",
"name": "Bolton NHS Foundation Trust"
}
],
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination"
}
],
"bids": {
"statistics": [
{
"id": "3",
"measure": "bids",
"value": 1
},
{
"id": "4",
"measure": "bids",
"value": 1
},
{
"id": "5",
"measure": "bids",
"value": 1
},
{
"id": "6",
"measure": "bids",
"value": 1
},
{
"id": "7",
"measure": "bids",
"value": 1
},
{
"id": "8",
"measure": "bids",
"value": 1
},
{
"id": "9",
"measure": "bids",
"value": 1
},
{
"currency": "GBP",
"id": "1",
"measure": "lowestValidBidValue",
"value": 0.01
},
{
"currency": "GBP",
"id": "2",
"measure": "highestValidBidValue",
"value": 18.06
}
]
},
"buyer": {
"id": "GB-NHS-(Q75)",
"name": "NHS England - North West"
},
"contracts": [
{
"awardID": "046179-2025-Lot 1 - Cheshire West and Chester-1",
"dateSigned": "2025-07-29T00:00:00+01:00",
"id": "046179-2025-Lot 1 - Cheshire West and Chester-1",
"status": "active",
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination",
"value": {
"amount": 18.06,
"currency": "GBP"
}
},
{
"awardID": "046179-2025-Lot 2 - Blackburn with Darwen-2",
"dateSigned": "2025-07-29T00:00:00+01:00",
"id": "046179-2025-Lot 2 - Blackburn with Darwen-2",
"status": "active",
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination",
"value": {
"amount": 18.06,
"currency": "GBP"
}
},
{
"awardID": "046179-2025-Lot 3 - Wirral-3",
"dateSigned": "2025-07-29T00:00:00+01:00",
"id": "046179-2025-Lot 3 - Wirral-3",
"status": "active",
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination",
"value": {
"amount": 18.06,
"currency": "GBP"
}
},
{
"awardID": "046179-2025-Lot 4 - Rochdale, Oldham, and Bury-4",
"dateSigned": "2025-07-29T00:00:00+01:00",
"id": "046179-2025-Lot 4 - Rochdale, Oldham, and Bury-4",
"status": "active",
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination",
"value": {
"amount": 18.06,
"currency": "GBP"
}
},
{
"awardID": "046179-2025-Lot 5 - Tameside, Stockport, and Wigan-5",
"dateSigned": "2025-07-29T00:00:00+01:00",
"id": "046179-2025-Lot 5 - Tameside, Stockport, and Wigan-5",
"status": "active",
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination",
"value": {
"amount": 18.06,
"currency": "GBP"
}
},
{
"awardID": "046179-2025-Lot 6 - Manchester, Trafford and Salford-6",
"dateSigned": "2025-07-29T00:00:00+01:00",
"id": "046179-2025-Lot 6 - Manchester, Trafford and Salford-6",
"status": "active",
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination",
"value": {
"amount": 18.06,
"currency": "GBP"
}
},
{
"awardID": "046179-2025-Lot 7 - Bolton-7",
"dateSigned": "2025-08-04T00:00:00+01:00",
"id": "046179-2025-Lot 7 - Bolton-7",
"status": "active",
"title": "NHSE1063-64 - Mpox Vaccination and Gonorrhoea Vaccination",
"value": {
"amount": 18.06,
"currency": "GBP"
}
}
],
"date": "2025-08-05T14:33:54+01:00",
"description": "The Relevant Authorities intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nDetails of individual making decisions:\nPublic Health Senior Manager, Commissioning Directorate, NHS England - North West.\nPublic Health Manager (Commissioning), NHS England/ NHS Greater Manchester Integrated Care.\nScreening and Immunisation Coordinator, GM S7a Screening and Immunisation Team, Population Health Directorate, NHS England Greater Manchester.\nAssistant Director of Finance - Direct Commissioning, NHS Greater Manchester.\nFinance Manager (Public Health, COVID \u0026 Medical Revalidation)\nNHS England - North West.\nThere were no conflicts of interests identified.",
"id": "046179-2025",
"initiationType": "tender",
"language": "en",
"ocid": "ocds-h6vhtk-0581a5",
"parties": [
{
"address": {
"countryName": "United Kingdom",
"locality": "Liverpool",
"postalCode": "L3 4BL",
"region": "UKD",
"streetAddress": "Regatta Place, Brunswick Business Park, Summers Road"
},
"contactPoint": {
"email": "necsu.psrprocurement@nhs.net"
},
"details": {
"classifications": [
{
"description": "Body governed by public law",
"id": "BODY_PUBLIC",
"scheme": "TED_CA_TYPE"
},
{
"description": "Health",
"id": "07",
"scheme": "COFOG"
}
],
"url": "https://www.england.nhs.uk/north-west/contact-us/"
},
"id": "GB-NHS-(Q75)",
"identifier": {
"id": "(Q75)",
"legalName": "NHS England - North West",
"scheme": "GB-NHS"
},
"name": "NHS England - North West",
"roles": [
"buyer"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "MANCHESTER",
"postalCode": "M1 3BN",
"region": "UKD",
"streetAddress": "4th floor Piccadilly place, London Road"
},
"contactPoint": {
"email": "necsu.psrprocurement@nhs.net"
},
"details": {
"url": "https://www.england.nhs.uk/north-west/contact-us/"
},
"id": "GB-NHS-(Q83)",
"identifier": {
"id": "(Q83)",
"legalName": "NHS England - North West Greater Manchester",
"scheme": "GB-NHS"
},
"name": "NHS England - North West Greater Manchester",
"roles": [
"buyer"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Cheshire",
"postalCode": "WA7 4QX",
"region": "UKD",
"streetAddress": "The Heath Business \u0026 Technical Park, Runcorn"
},
"details": {
"scale": "large",
"url": "https://www.hcrgcaregroup.com/"
},
"id": "GB-COH-07557877",
"identifier": {
"id": "07557877",
"legalName": "HCRG Care Services Limited",
"scheme": "GB-COH"
},
"name": "HCRG Care Services Limited",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Truro,",
"postalCode": "TR1 2LH",
"region": "UKK3",
"streetAddress": "Penhaligon House, Green Street,"
},
"details": {
"scale": "sme",
"url": "https://www.brook.org.uk/"
},
"id": "GB-COH-02466940",
"identifier": {
"id": "02466940",
"legalName": "Brook Young People",
"scheme": "GB-COH"
},
"name": "Brook Young People",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Birkenhead",
"postalCode": "CH42 0LQ",
"region": "UKD",
"streetAddress": "Derby Road"
},
"details": {
"scale": "large",
"url": "https://www.wchc.nhs.uk/"
},
"id": "GB-NHS-(RY7)",
"identifier": {
"id": "(RY7)",
"legalName": "Wirral Community Health and Care NHS Foundation Trust",
"scheme": "GB-NHS"
},
"name": "Wirral Community Health and Care NHS Foundation Trust",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Liversedge",
"postalCode": "WF15 6LP",
"region": "UKE4",
"streetAddress": "Eddercliffe Health Centre, Bradford Road,"
},
"details": {
"scale": "large",
"url": "https://www.locala.org.uk/"
},
"id": "GB-COH-07584906",
"identifier": {
"id": "07584906",
"legalName": "Locala Community Partnerships CIC",
"scheme": "GB-COH"
},
"name": "Locala Community Partnerships CIC",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "MANCHESTER",
"postalCode": "M13 9W",
"region": "UKD",
"streetAddress": "Cobbett House, Oxford Road"
},
"details": {
"scale": "large",
"url": "https://mft.nhs.uk/"
},
"id": "GB-NHS-(R0A)",
"identifier": {
"id": "(R0A)",
"legalName": "Manchester University NHS Foundation Trust",
"scheme": "GB-NHS"
},
"name": "Manchester University NHS Foundation Trust",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Bolton",
"postalCode": "BL4 0JR",
"region": "UKD",
"streetAddress": "The Royal Bolton Hospital, Minerva Road, Farnworth"
},
"details": {
"scale": "large",
"url": "https://www.boltonft.nhs.uk/"
},
"id": "GB-NHS-(RMC)",
"identifier": {
"id": "(RMC)",
"legalName": "Bolton NHS Foundation Trust",
"scheme": "GB-NHS"
},
"name": "Bolton NHS Foundation Trust",
"roles": [
"supplier"
]
},
{
"address": {
"countryName": "United Kingdom",
"locality": "Liverpool",
"postalCode": "L3 4BL",
"streetAddress": "Regatta Place, Brunswick Business Park, Summers Road"
},
"contactPoint": {
"email": "necsu.psrprocurement@nhs.net"
},
"details": {
"url": "https://www.england.nhs.uk/north-west/contact-us/"
},
"id": "GB-FTS-157087",
"identifier": {
"legalName": "NHS England - North West"
},
"name": "NHS England - North West",
"roles": [
"reviewBody"
]
}
],
"tag": [
"award",
"contract"
],
"tender": {
"classification": {
"description": "Miscellaneous health services",
"id": "85140000",
"scheme": "CPV"
},
"coveredBy": [
"GPA"
],
"description": "NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nNHSE NW\n\u2022\tLot 1 - Cheshire West \u0026 Chester \n\u2022\tLot 2 - Blackburn with Darwen \n\u2022\tLot 3 - Wirral\nNHSE GM\n\u2022\tLot 4 - Rochdale, Oldham, Bury\n\u2022\tLot 5 - Tameside, Stockport, Wigan \n\u2022\tLot 6 - Manchester, Trafford and Salford\n\u2022\tLot 7 - Bolton- MPOX",
"id": "NHSE1063-64",
"items": [
{
"additionalClassifications": [
{
"description": "Miscellaneous health services",
"id": "85140000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKD"
}
],
"deliveryLocation": {
"description": "Lot 1 - Cheshire West and Chester"
},
"id": "1",
"relatedLot": "1"
},
{
"additionalClassifications": [
{
"description": "Miscellaneous health services",
"id": "85140000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKD"
}
],
"deliveryLocation": {
"description": "Lot 2 - Blackburn with Darwen"
},
"id": "2",
"relatedLot": "2"
},
{
"additionalClassifications": [
{
"description": "Miscellaneous health services",
"id": "85140000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKD"
}
],
"deliveryLocation": {
"description": "Lot 3 - Wirral"
},
"id": "3",
"relatedLot": "3"
},
{
"additionalClassifications": [
{
"description": "Miscellaneous health services",
"id": "85140000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKD"
}
],
"deliveryLocation": {
"description": "Lot 4 - Rochdale, Oldham, Bury"
},
"id": "4",
"relatedLot": "4"
},
{
"additionalClassifications": [
{
"description": "Miscellaneous health services",
"id": "85140000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKD"
}
],
"deliveryLocation": {
"description": "Lot 5 - Tameside, Stockport, Wigan"
},
"id": "5",
"relatedLot": "5"
},
{
"additionalClassifications": [
{
"description": "Miscellaneous health services",
"id": "85140000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKD"
}
],
"deliveryLocation": {
"description": "Lot 6 - Manchester, Trafford and Salford"
},
"id": "6",
"relatedLot": "6"
},
{
"additionalClassifications": [
{
"description": "Miscellaneous health services",
"id": "85140000",
"scheme": "CPV"
}
],
"deliveryAddresses": [
{
"region": "UKD"
}
],
"deliveryLocation": {
"description": "Lot 7 - Bolton"
},
"id": "7",
"relatedLot": "7"
}
],
"legalBasis": {
"id": "32014L0024",
"scheme": "CELEX"
},
"lots": [
{
"awardCriteria": {
"criteria": [
{
"description": "100",
"name": "Patient Choice",
"type": "quality"
},
{
"description": "100",
"name": "Patient Choice",
"type": "cost"
}
]
},
"description": "NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocations/Lots:\nNHSE NW\n\u2022\tLot 1 - Cheshire West \u0026 Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.\n\u2022\tLot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\nNHSE GM\n\u2022\tLot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\n\u2022\tLot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority",
"hasOptions": false,
"id": "1",
"status": "cancelled",
"title": "Lot 1 - Cheshire West and Chester"
},
{
"awardCriteria": {
"criteria": [
{
"description": "100",
"name": "Patient Choice",
"type": "quality"
},
{
"description": "100",
"name": "Patient Choice",
"type": "cost"
}
]
},
"description": "NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocations/Lots:\nNHSE NW\n\u2022\tLot 1 - Cheshire West \u0026 Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.\n\u2022\tLot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\nNHSE GM\n\u2022\tLot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\n\u2022\tLot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority",
"hasOptions": false,
"id": "2",
"status": "cancelled",
"title": "Lot 2 - Blackburn with Darwen"
},
{
"awardCriteria": {
"criteria": [
{
"description": "100",
"name": "Patient Choice",
"type": "quality"
},
{
"description": "100",
"name": "Patient Choice",
"type": "cost"
}
]
},
"description": "NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocations/Lots:\nNHSE NW\n\u2022\tLot 1 - Cheshire West \u0026 Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.\n\u2022\tLot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\nNHSE GM\n\u2022\tLot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\n\u2022\tLot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority",
"hasOptions": false,
"id": "3",
"status": "cancelled",
"title": "Lot 3 - Wirral"
},
{
"awardCriteria": {
"criteria": [
{
"description": "100",
"name": "Patient Choice",
"type": "quality"
},
{
"description": "100",
"name": "Patient Choice",
"type": "cost"
}
]
},
"description": "NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocations/Lots:\nNHSE NW\n\u2022\tLot 1 - Cheshire West \u0026 Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.\n\u2022\tLot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\nNHSE GM\n\u2022\tLot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\n\u2022\tLot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority",
"hasOptions": false,
"id": "4",
"status": "cancelled",
"title": "Lot 4 - Rochdale, Oldham, Bury"
},
{
"awardCriteria": {
"criteria": [
{
"description": "100",
"name": "Patient Choice",
"type": "quality"
},
{
"description": "100",
"name": "Patient Choice",
"type": "cost"
}
]
},
"description": "NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocations/Lots:\nNHSE NW\n\u2022\tLot 1 - Cheshire West \u0026 Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.\n\u2022\tLot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\nNHSE GM\n\u2022\tLot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\n\u2022\tLot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority",
"hasOptions": false,
"id": "5",
"status": "cancelled",
"title": "Lot 5 - Tameside, Stockport, Wigan"
},
{
"awardCriteria": {
"criteria": [
{
"description": "100",
"name": "Patient Choice",
"type": "quality"
},
{
"description": "100",
"name": "Patient Choice",
"type": "cost"
}
]
},
"description": "NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocations/Lots:\nNHSE NW\n\u2022\tLot 1 - Cheshire West \u0026 Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.\n\u2022\tLot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\nNHSE GM\n\u2022\tLot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\n\u2022\tLot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority",
"hasOptions": false,
"id": "6",
"status": "cancelled",
"title": "Lot 6 - Manchester, Trafford and Salford"
},
{
"awardCriteria": {
"criteria": [
{
"description": "100",
"name": "Patient Choice",
"type": "quality"
},
{
"description": "100",
"name": "Patient Choice",
"type": "cost"
}
]
},
"description": "NHS England - North West and NHS England Greater Manchester (the Relevant Authorities) intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.\nFollowing the government\u0027s acceptance of the Joint Committee on Vaccination and Immunisation (JCVI) advice that the NHS should implement: \n\u2022\ta routine mpox pre-exposure vaccination programme building on the existing offer JCVI statement on mpox vaccination as a routine programme - GOV.UK \n\u2022\ta routine opportunistic gonorrhoea vaccination programme JCVI advice on the use of meningococcal B vaccination for the prevention of gonorrhoea - GOV.UK \nThe Relevant Authorities is now seeking suitable providers by no later than 01 September 2025 necsu.psrprocurement@nhs.net to deliver the vaccinations alongside existing vaccination programmes (HPV GBMSM) delivered in place-based Local Authority commissioned sexual health services. Providers must deliver sexual health services in identified localities and work with partners to ensure effective programme coverage and equity of access to the local eligible population. \nEligibility \nThe JCVI advised that the vaccination programmes, which have similar eligibility criteria, should primarily target gay, bisexual and other men who have sex with men (GBMSM) who meet the eligibility criteria and are at highest risk of exposure to Mpox and Gonorrhoea. There may also be a small number of individuals other than GBMSM with a similar risk of infection as the eligible GBMSM groups who can be offered the vaccines. \nIndividuals should be identified through sexual health services using markers of high risk of infection. This includes a recent history of multiple sexual partners or recent bacterial sexually transmitted infection. Full details on the eligible cohorts for each programme are available in the service specifications for each programme. \nActivity/funding \nFunding of \u00a310.06 will be provided for each dose of vaccine delivered to members of the identified cohort. An additional \u00a38.00 per vaccination delivered will be provided in 2025/26 to support mobilisation. This additional implementation payment will be reviewed in advance of 2026/27 contract year. \nAs these are newly developed programmes, no baseline activity level for these vaccinations is available. Activity delivered in 2025/26 will be used to determine an Indicative Activity Plan for 2026/27 and future contract years. \nDelivery date \nProviders should build on the existing delivery of vaccinations including HPV GBMSM and the accelerated Mpox vaccination programme (where implemented) and make arrangements to deliver to the eligible population accessing their services from August 2025. Providers should be offering both vaccines by no later than 01 September 2025. \nProvider Eligibility Criteria: \nEligible providers must: \n\u2022\tHold a current Local Authority contract for the delivery of Sexual Health Services for one or more of the Lots/Localities as identified in this procurement process. \n\u2022\tPass all questions within the Regulation 20 questionnaire parts 1 and part 2 and the associated quality and financial stability assessment in part 3 of the questionnaire. \nContract Term: \nTo commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority:\nLocations/Lots:\nNHSE NW\n\u2022\tLot 1 - Cheshire West \u0026 Chester - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 2 - Blackburn with Darwen - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2026.\n\u2022\tLot 3 - Wirral - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\nNHSE GM\n\u2022\tLot 4 - Rochdale, Oldham, Bury - MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 5 - Tameside, Stockport, Wigan - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2031.\n\u2022\tLot 6 - Manchester, Trafford and Salford - MPOX as existing service and Gonorrhoea as new service to commence 01 August 2025 expiry 31 March 2032.\n\u2022\tLot 7 - Bolton- MPOX as new service and Gonorrhoea as new service to commence 01 August 2025 expiry 30 December 2031. Additional information: To commence in August 2025 and providers should be offering both vaccines by no later than 01 September 2025. The contract term will be co-terminus with the Local Authority contract for Sexual Health Services as highlighted for each Location/Lot which includes any permissible extension periods which would be subject to the enactment of the Local Authority",
"hasOptions": false,
"id": "7",
"status": "cancelled",
"title": "Lot 7 - Bolton"
}
],
"mainProcurementCategory": "services",
"procurementMethod": "limited",
"procurementMethodDetails": "Award procedure without prior publication of a call for competition",
"procurementMethodRationale": "The Relevant Authorities intends to award these contracts under the Direct Award Process B under the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to these awards.",
"procurementMethodRationaleClassifications": [
{
"description": "The procurement falls outside the scope of application of the directive",
"id": "D_OUTSIDE_SCOPE",
"scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL"
}
],
"status": "complete",
"title": "NHSE1063-64 Mpox Vaccination and Gonorrhoea Vaccination"
}
}